Genzyme Support Services
Patient & Caregiver Portal

The confidential and convenient connection to personalized support for people living with rare genetic diseases

Get 24/7 access to the support and information you need

If you or a loved one are living with — or think you may have — Gaucher disease, managing your time and energy is important. The Genzyme Support Services Patient & Caregiver Portal was developed to provide you with the convenience of 24/7 online access to the personalized support and information you need.

Confidential support is just a few clicks away

The Patient & Caregiver Portal is your convenient online connection to:

Dedicated Genzyme Case Manager
Count on connecting with the same person. Every time.

Communication Dashboard
Stay in touch. Stay informed.

Request Assistance
Get help when you need it

Personalized Resource Library
Get content that’s relevant to you and your family

Secure Online Environment
Your privacy is protected

Desktop and Mobile Access
Stay connected at home or on the go

Sign up today!
Visit to get started.

Indication & Usage

Cerezyme® (imiglucerase for injection) is indicated for long-term enzyme replacement therapy for pediatric and adult patients with a confirmed diagnosis of Type 1 Gaucher disease that results in one or more of the following conditions:

  1. anemia (low red blood cell count)
  2. thrombocytopenia (low blood platelet count)
  3. bone disease
  4. hepatomegaly or splenomegaly (enlarged liver or spleen)

Important Safety Information

Approximately 15% of patients have developed immune responses (antibodies) to Cerezyme during the first year of therapy. These patients have a higher risk of an allergic reaction (hypersensitivity). Your doctor may periodically test for the presence of antibodies. Serious allergic reactions (anaphylaxis) have been reported in less than 1% of patients. Symptoms suggestive of allergic reaction happened in approximately 7% of patients, and include itching, flushing, hives, swelling, chest discomfort, shortness of breath, coughing, cyanosis (a bluish discoloration of the skin due to diminished oxygen), and low blood pressure. If you have had an allergic reaction to Cerezyme, you and your doctor should use caution if you continue to receive treatment with Cerezyme.

High blood pressure in the arteries of the lungs (pulmonary hypertension) and pneumonia have been observed in less than 1% of patients during treatment with Cerezyme. These are also known complications of Gaucher disease regardless of treatment. If you experience symptoms such as shortness of breath or chest pain, with or without fever, contact your doctor.

Approximately 14% of patients have experienced side effects related to treatment with Cerezyme. Some of these reactions occur at the site of injection such as discomfort, itching, burning, swelling or uninfected abscess. Other side effects, each of which was reported by less than 2% of patients, include nausea, abdominal pain, vomiting, diarrhea, rash, fatigue, headache, fever, dizziness, chills, backache, and rapid heart rate. Temporary swelling in the legs has also been observed with drugs like Cerezyme.

Please see Full Prescribing Information (PDF).